Loading clinical trials...
Loading clinical trials...
A Single Center, Randomized, Double-blind, Placebo-controlled, Parallel Study to Investigate the Ability of a Euglena Beta Glucan Supplementation to Augment Immune Function in Endurance Athletes
Conditions
Interventions
Whole Cell Euglena containing Beta Glucan
Placebo
Locations
1
Canada
KGK Science Inc.
London, Ontario, Canada
Start Date
March 28, 2018
Primary Completion Date
September 1, 2018
Completion Date
December 1, 2018
Last Updated
December 5, 2018
Lead Sponsor
Kemin Foods LC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions